Pilot Clinical Trial of Hedgehog Pathway Inhibitor GDC-0449 (Vismodegib) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma

Overview of attention for article published in Clinical Cancer Research, November 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

blogs: 1 blog
twitter: 12 X users

patent: 1 patent

Readers on

mendeley: 172 Mendeley
citeulike: 1 CiteULike

So far, Altmetric has seen 12 X posts from 12 X users, with an upper bound of 80,186 followers.

Pilot clinical trial of hedgehog pathway inhibitor GDC-0449 (vismodegib) in combination with gemcitabine in… http://t.co/Qyvcof5Gvp

Pilot Clinical Trial of Hedgehog Pathway Inhibitor GDC-0449 (Vismodegib) in Combination with... http://t.co/3XSvLCu1J1

Genentech targeted #cancerSC via HH inhibitor - did well in experiment http://t.co/dqOk9QJQ2l failed in trial http://t.co/ZYgqnWc1U2

Pilot trial of #Hedgehog inhibitor #vismodegib + gemcitabine in #PancreaticCancer - no improvement in PFS/OS over Gem http://t.co/pSOc94MIZZ

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 8 additional X posts.